Fatty acid binding protein-4 and general anesthesia

Application and related mechanism of fatty acid-binding protein-4 in assessing muscle strength recovery after recovery from general anesthesia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051834

Enrollment

Unknown

Registered

2021-10-06

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia patients undergoing elective hip surgery

Interventions

case series:General anesthesia with endotracheal intubation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 400 cases of general anesthesia patients undergoing elective hip surgery, American Society of Anesthesiologist (ASA) grade I-III, 200 males and 200 females, with normal cardiac function; 2. Agree to the content of the informed notice of this study.

Exclusion criteria

Exclusion criteria: 1. Preoperative use of glucose-regulating drugs, abnormal liver function, cardiac insufficiency, arrhythmia and coronary heart disease; 2. Intraoperative use of vasoactive drugs; 3. Patients with cognitive impairment and history of mental illness.

Design outcomes

Primary

Measure	Time frame
myodynamia;fatty acid binding protein-4;cholinesterase;neuromuscular junction;	—

Countries

China

Contacts

Public ContactWeng Xiaojian

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

jxw1860@163.com+86 13621733696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026